159 related articles for article (PubMed ID: 31275454)
1. Expression and Clinical Relevance of SOX9 in Gastric Cancer.
Mesquita P; Freire AF; Lopes N; Gomes R; Azevedo D; Barros R; Pereira B; Cavadas B; Pópulo H; Boaventura P; David L; Pereira L; Almeida R
Dis Markers; 2019; 2019():8267021. PubMed ID: 31275454
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic relevance of SOX9 stem cell factor in gastric cancer.
Carrasco-Garcia E; Álvarez-Satta M; García-Puga M; Ribeiro ML; Arevalo S; Arauzo-Bravo M; Matheu A
Expert Opin Ther Targets; 2019 Feb; 23(2):143-152. PubMed ID: 30572738
[TBL] [Abstract][Full Text] [Related]
3. Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
Link H; Angele M; Schüller M; Ganschow P; Machetanz L; Guba M; Werner J; Kirchner T; Neumann J
BMC Cancer; 2018 Apr; 18(1):483. PubMed ID: 29703178
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of Sry-related High Mobility Group Box 9 and Gastrokine-1 in Gastric Cancer and Their Relationships with Prognosis].
Chen JB; Xu GS; Cai XJ; Liu HT; Sun KL; Luo X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):315-322. PubMed ID: 31282324
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of SOX9 expression and its relationship with carcinoembryonic antigen-related cell adhesion molecule 1 in gastric neoplastic and nonneoplastic lesions.
Liu JN; Shang Guan YM; Qi YZ; Wang HB; Zhang TG; Zhou CJ
Ann Diagn Pathol; 2012 Aug; 16(4):235-44. PubMed ID: 22209504
[TBL] [Abstract][Full Text] [Related]
6. Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma.
Luo W; Nagaria TS; Sun H; Ma J; Lombardo JL; Bassett R; Cao AC; Tan D
Pathol Oncol Res; 2022; 28():1610293. PubMed ID: 35221802
[TBL] [Abstract][Full Text] [Related]
7. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
8. [Association of SOX9 expression and prognosis in patients with gastric cancer].
Shao CM; Shao QS; Yao HB; Zhao ZK; Xu J; Zhao ZS; Tao HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):736-9. PubMed ID: 22851082
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers.
Choi YJ; Song JH; Yoon JH; Choi WS; Nam SW; Lee JY; Park WS
Gastric Cancer; 2014 Apr; 17(2):247-54. PubMed ID: 23812904
[TBL] [Abstract][Full Text] [Related]
10. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
12. SOX9 expression predicts relapse of stage II colon cancer patients.
Marcker Espersen ML; Linnemann D; Christensen IJ; Alamili M; Troelsen JT; Høgdall E
Hum Pathol; 2016 Jun; 52():38-46. PubMed ID: 26980019
[TBL] [Abstract][Full Text] [Related]
13. TRIM15 Exerts Anti-Tumor Effects Through Suppressing Cancer Cell Invasion in Gastric Adenocarcinoma.
Chen W; Lu C; Hong J
Med Sci Monit; 2018 Nov; 24():8033-8041. PubMed ID: 30412518
[TBL] [Abstract][Full Text] [Related]
14. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract][Full Text] [Related]
15. SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated.
Li G; Chen H; Ren C
Gastroenterology; 2023 Oct; 165(4):1094. PubMed ID: 37414194
[No Abstract] [Full Text] [Related]
16. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
Bösch F; Todorova R; Link H; Westphalen CB; Boeck S; Heinemann V; Werner J; Kirchner T; Angele MK; Neumann J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2689-2697. PubMed ID: 31541339
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.
Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G
Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
